• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症患者观察性研究和常规护理的吞咽困难筛查工具的开发与评估

Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients.

作者信息

Borean Michael, Shani Kishan, Brown M Catherine, Chen Judy, Liang Mindy, Karkada Joel, Kooner Simranjit, Doherty Mark K, O'Kane Grainne M, Jang Raymond, Elimova Elena, Wong Rebecca K, Darling Gail E, Xu Wei, Howell Doris, Liu Geoffrey

机构信息

Division of Medical Oncology Princess Margaret Cancer Centre and Departments of Medicine and Epidemiology, Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada.

Odette Cancer Centre University of Toronto Toronto Ontario Canada.

出版信息

Health Sci Rep. 2018 May 21;1(7):e48. doi: 10.1002/hsr2.48. eCollection 2018 Jul.

DOI:10.1002/hsr2.48
PMID:30623085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6266365/
Abstract

BACKGROUND AND AIMS

Dysphagia can be associated with significant morbidity in cancer patients. We aimed to develop and evaluate dysphagia screener tools for use in observational studies (phase 1) and for routine symptom monitoring in clinical care (phase 2).

METHODS

Various dysphagia or odynophagia screening questions, selected after an expert panel reviewed the content, criterion, and construct validity, were compared with either functional assessment of cancer therapy - esophageal cancer (FACT-E) Swallowing Index Cut-Off Values or to questions adapted from the Patient Reported Outcomes for Common Terminology Criteria for Adverse Events. Sensitivity, specificity, and patient acceptability were assessed.

RESULTS

In Phase 1 (n = 178 esophageal cancer patients), the screening question "How are you currently eating?" had the highest sensitivities and specificities against various Swallowing Index Cut-Off Value cut-offs, with the best optimal cutoff associated with weight loss (80% sensitivity and 75% specificity). In phase 2 (255 head and neck, gastro-esophageal, and thoracic cancer patients), a single question screener ("Do you experience any difficulty or pain upon swallowing?") versus a Patient Reported Outcomes for Common Terminology Criteria for Adverse Events-like gold standard generated sensitivities between 86% and 94% and specificities between 93% and 100%. This screening question (+/- follow-up questions) had a median completion time of under 2 minutes, and >90% of patients were willing to complete the survey electronically, did not feel that survey made clinic visit more difficult, and did not find the questions upsetting or distressful.

CONCLUSION

Our results demonstrate that these screener tools ("How are you currently eating?", "Do you experience any difficulty or pain upon swallowing?") can effectively screen dysphagia symptoms without increasing cancer outpatient clinic burden, both in observational studies and for routine clinical monitoring.

摘要

背景与目的

吞咽困难可能与癌症患者的严重发病情况相关。我们旨在开发并评估用于观察性研究(第1阶段)以及临床护理中常规症状监测(第2阶段)的吞咽困难筛查工具。

方法

在一个专家小组对内容、标准和结构效度进行审查后,挑选出各种吞咽困难或吞咽疼痛筛查问题,并将其与癌症治疗功能评估-食管癌(FACT-E)吞咽指数临界值或根据不良事件通用术语标准的患者报告结局改编的问题进行比较。评估了敏感性、特异性和患者可接受性。

结果

在第1阶段(n = 178例食管癌患者),筛查问题“你目前进食情况如何?”针对各种吞咽指数临界值具有最高的敏感性和特异性,与体重减轻相关的最佳最佳临界值具有80%的敏感性和75%的特异性。在第2阶段(255例头颈部、胃食管和胸段癌症患者),一个单一问题筛查器(“你吞咽时是否有任何困难或疼痛?”)与一个类似不良事件通用术语标准的患者报告结局金标准相比,敏感性在86%至94%之间,特异性在93%至100%之间。这个筛查问题(±后续问题)的中位完成时间不到2分钟,超过90%的患者愿意以电子方式完成调查,不觉得调查使门诊就诊更困难,也不觉得问题令人不安或痛苦。

结论

我们的结果表明,这些筛查工具(“你目前进食情况如何?”,“你吞咽时是否有任何困难或疼痛?”)在观察性研究和常规临床监测中都能有效筛查吞咽困难症状,而不会增加癌症门诊负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7b/6266365/3b86a213cbba/HSR2-1-e48-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7b/6266365/024d7fbf222a/HSR2-1-e48-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7b/6266365/f8b0cf78ddd1/HSR2-1-e48-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7b/6266365/3b86a213cbba/HSR2-1-e48-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7b/6266365/024d7fbf222a/HSR2-1-e48-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7b/6266365/f8b0cf78ddd1/HSR2-1-e48-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc7b/6266365/3b86a213cbba/HSR2-1-e48-g003.jpg

相似文献

1
Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients.用于癌症患者观察性研究和常规护理的吞咽困难筛查工具的开发与评估
Health Sci Rep. 2018 May 21;1(7):e48. doi: 10.1002/hsr2.48. eCollection 2018 Jul.
2
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.在癌症门诊患者中使用通用不良事件术语标准和其他患者报告症状结局工具进行常规评估的可接受性:玛格丽特公主癌症中心的经验。
Oncologist. 2019 Nov;24(11):e1219-e1227. doi: 10.1634/theoncologist.2018-0830. Epub 2019 Aug 13.
3
Screening for aspiration risk associated with dysphagia in acute stroke.筛查急性脑卒中吞咽困难相关的吸入风险。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012679. doi: 10.1002/14651858.CD012679.pub2.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Patient-Reported Outcome Measures and Dosimetric Correlates for Early Detection of Acute Radiation Therapy-Related Esophagitis.患者报告的结局测量指标与急性放射性食管炎早期检测的剂量学相关性。
Pract Radiat Oncol. 2021 May-Jun;11(3):185-192. doi: 10.1016/j.prro.2020.10.009. Epub 2020 Oct 31.
6
A modified screening tool for autism (Checklist for Autism in Toddlers [CHAT-23]) for Chinese children.一种针对中国儿童的改良版自闭症筛查工具(幼儿自闭症筛查清单[CHAT-23])。
Pediatrics. 2004 Aug;114(2):e166-76. doi: 10.1542/peds.114.2.e166.
7
Correlations Between Patient-Reported Dysphagia Screening and Penetration-Aspiration Scores in Head and Neck Cancer Patients Post-oncological Treatment.头颈部癌症患者肿瘤治疗后患者报告的吞咽困难筛查与误吸评分之间的相关性
Dysphagia. 2018 Apr;33(2):206-215. doi: 10.1007/s00455-017-9847-6. Epub 2017 Sep 8.
8
Diagnostic utility of different dysphagia screening tools to detect dysphagia in individuals with amyotrophic lateral sclerosis.不同吞咽困难筛查工具对肌萎缩侧索硬化症患者吞咽困难的诊断效用
Neurol Sci. 2023 Nov;44(11):3919-3927. doi: 10.1007/s10072-023-06918-2. Epub 2023 Jun 27.
9
SIP SMART: a parallel group randomised feasibility trial of a tailored pre-treatment swallowing intervention package compared with usual care for patients with head and neck cancer.SIP SMART 研究:一项针对头颈部癌症患者的个体化治疗前吞咽干预方案与常规治疗的平行分组随机可行性试验。
BMC Cancer. 2020 Apr 29;20(1):360. doi: 10.1186/s12885-020-06877-3.
10

本文引用的文献

1
Patient Adherence to Dysphagia Recommendations: A Systematic Review.患者对吞咽困难建议的依从性:一项系统评价。
Dysphagia. 2018 Apr;33(2):173-184. doi: 10.1007/s00455-017-9852-9. Epub 2017 Sep 30.
2
Standardization of health outcomes assessment for depression and anxiety: recommendations from the ICHOM Depression and Anxiety Working Group.抑郁症和焦虑症健康结局评估的标准化:国际协调统一医学成果测量(ICHOM)抑郁症和焦虑症工作组的建议
Qual Life Res. 2017 Dec;26(12):3211-3225. doi: 10.1007/s11136-017-1659-5. Epub 2017 Aug 7.
3
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment.
一项评估常规癌症治疗期间症状监测的患者报告结局的试验的总生存结果。
JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156.
4
Patient-reported outcomes in the evaluation of toxicity of anticancer treatments.患者报告的癌症治疗毒性评估结果。
Nat Rev Clin Oncol. 2016 May;13(5):319-25. doi: 10.1038/nrclinonc.2015.222. Epub 2016 Jan 20.
5
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.诱导化疗联合放化疗治疗 IIIA/N2 期非小细胞肺癌:一项 3 期随机试验。
Lancet. 2015 Sep 12;386(9998):1049-56. doi: 10.1016/S0140-6736(15)60294-X. Epub 2015 Aug 11.
6
The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up.埃德蒙顿症状评估系统(ESAS)作为一种筛查工具,用于评估治愈或随访中的实体瘤或血液恶性肿瘤非晚期患者的抑郁和焦虑症状。
Support Care Cancer. 2014 Mar;22(3):783-93. doi: 10.1007/s00520-013-2034-x. Epub 2013 Nov 26.
7
The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression.埃德蒙顿症状评估系统在筛查焦虑和抑郁中的效用。
Eur J Cancer Care (Engl). 2013 Jan;22(1):60-9. doi: 10.1111/j.1365-2354.2012.01369.x. Epub 2012 Jun 14.
8
Swallowing dysfunction in cancer patients.癌症患者的吞咽功能障碍。
Support Care Cancer. 2012 Mar;20(3):433-43. doi: 10.1007/s00520-011-1342-2. Epub 2011 Dec 29.
9
Cancer cachexia.癌症恶病质
J Oral Maxillofac Pathol. 2011 Sep;15(3):257-60. doi: 10.4103/0973-029X.86670.
10
Cancer cachexia: mechanisms and clinical implications.癌症恶病质:机制与临床意义。
Gastroenterol Res Pract. 2011;2011:601434. doi: 10.1155/2011/601434. Epub 2011 Jun 13.